Our goal is.... | PVCT Message Board Posts

Provectus Biopharmaceuticals, Inc.

  PVCT website
    As promised, anyone interested can click this link to view the survey results and read some of our initial takeaways from the data collected. Thanks again to all who participated! 

PVCT   /  Message Board  /  Read Message



Rec'd By
Authored By
Minimum Recs
Previous Message  Next Message   Post Message   Post a Reply return to message boardtop of board
Msg  55488 of 55604  at  5/14/2021 11:52:07 AM  by


The following message was updated on 5/14/2021 11:54:25 AM.

Our goal is....

Our goal in Nov 2018:
Provectus has begun work in support of extended 12-week administration (proof-of-concept or POC) for topically applied, non-steroidal PH-10: 
We are committed to properly monetizing this important asset for shareholders by developing PH-10 into a Phase 3-ready candidate, for both psoriasis and atopic dermatitis, in an efficient, effective, and industry-recognized manner.”
Our goal in May 2021 (from 10Q, Page 16):
The Company’s strategy is to (i) demonstrate 12-week single-agent administration proof-of-concept (“POC”) for topical PH-10 that includes (a) a preclinical safety study of extended 12-week administration (compared to, previously, four weeks), (b) a clinical mechanism of action study in atopic dermatitis 
Our goal for this POC work is to achieve Phase 3 trial-ready status for topical PH-10 in both psoriasis and atopic dermatitis.
Any guess for 2022 and 2023 goals (if company still exist at that time) ? 
Judas goat aka LTG and sheep will call me basher if I post this kind of information. But if I post PH-10 is worth Billions of dollars and BP interested in product and its just matter of time then I get 10 recommendations and I am pro PVCT.

     e-mail to a friend      printer-friendly     add to library      
| More
Recs: 2     Views: 0
Previous Message  Next Message   Post Message   Post a Reply return to message boardtop of board

Financial Market Data provided by